Serotonin and Premature Ejaculation: From Physiology to Patient Management

  • François Giuliano
    Corresponding author. Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, 104 bd Raymond Poincaré, 92380 Garches, France. Tel. +33 147107072; Fax: +33 147107615.
    PELVIPHARM Laboratories, Gif-sur-Yvette, France

    AP-HP, Neuro-Urology unit, Department of Physical Medicine and Rehabilitation, Raymond Poincaré Hospital, Garches, France
    Search for articles by this author
  • Pierre Clément
    PELVIPHARM Laboratories, Gif-sur-Yvette, France
    Search for articles by this author



      Premature ejaculation (PE), whose pathophysiology is still not clearly identified, is the most common male sexual dysfunction, yet it remains underdiagnosed and undertreated. The aims of this paper are to provide a scientific and pharmacologic rationale, and to discuss to what extent selective serotonin reuptake inhibitors (SSRIs) can help patients with PE.

      Materials and Methods

      A comprehensive evaluation of available published data included analysis of published full-length papers that were identified with Medline and Cancerlit from January 1981 to January 2006. Official proceedings of internationally known scientific societies held in the same time period were also assessed.


      The central ejaculatory neural circuit comprises spinal and cerebral areas that form a highly interconnected network. The sympathetic, parasympathetic, and somatic spinal centers, under the influence of sensory genital and cerebral stimuli integrated and processed at the spinal cord level, act in synergy to command physiologic events occurring during ejaculation. Experimental evidence indicates that serotonin (5-HT), throughout brain descending pathways, exerts an inhibitory role on ejaculation. To date, three 5-HT receptor subtypes (5-HT1A, 5-HT1B, and 5-HT2C) have been postulated to mediate 5-HT’s modulating activity on ejaculation. Pharmacologic manipulation of the serotonergic system has been performed in rats, with the antidepressant selective serotonin reuptake inhibitors (SSRIs) exhibiting the greatest efficacy in delaying ejaculation. The mechanism of action by which SSRIs modulate central 5-HT tone has been studied in depth, but gaps in this knowledge prevent an explanation of the efficacy of acute treatment in delaying ejaculation. Emerging clinical evidence indicates chronic and on-demand dosing of SSRIs has a beneficial effect for the treatment of men with PE, at least for paroxetine. On-demand dapoxetine, and SSRI with a short half-life, recently has been shown to significantly increase intravaginal latency time and PE patient-related outcomes in phase 3 clinical trials.


      Nowadays there is no doubt that PE can be treated effectively by SSRIs. Nevertheless their mechanism of action is not yet well understood and deserves more research. In particular it is not understood why all the SSRIs are not equal in terms of their ability to delay ejaculation. Therefore, there is a need for more research to better characterize the mechanism of action of SSRIs as well their clinical benefit in patients affected by PE.


      To read this article in full you will need to make a payment


      Subscribe to European Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Burnett A.L.
        The impact of sildenafil on molecular science and sexual health.
        Eur Urol. 2004; 46: 9-14
        • Papaharitou S.
        • Athanasiadis L.
        • Nakopoulou E.
        • et al.
        Erectile dysfunction and premature ejaculation are the most frequently self-reported sexual concerns: profiles of 9,536 men calling a helpline.
        Eur Urol. 2006; 49: 557-563
        • Lewis R.W.
        • Fugl-Meyer K.S.
        • Bosch R.
        • et al.
        Definitions, classifications and epidemiology of sexual dysfunction.
        in: Lue T.F. Basson R. Rosen R. Giuliano F. Khoury S. Montorsi F. Sexual medicine. Sexual dysfunctions in men and women. Health Publication, Oxford, UK2004: 37-72
        • Rowland D.
        • Perelman M.
        • Althof S.
        • et al.
        Self-reported premature ejaculation and aspects of sexual functioning and satisfaction.
        J Sex Med. 2004; 1: 225-232
        • Laumann E.O.
        • Paik A.
        • Rosen R.C.
        Sexual dysfunction in the United States: prevalence and predictors.
        JAMA. 1999; 281: 537-544
      1. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994. p. 509–11.

        • Lue T.F.
        • Giuliano F.
        • Montorsi F.
        • et al.
        Summary of the recommendations on sexual dysfunctions in men.
        J Sex Med. 2004; 1: 6-23
        • Goodman R.E.
        The management of premature ejaculation.
        J Int Med Res. 1977; 5: 78-79
        • Waldinger M.D.
        • Hengeveld M.W.
        • Zwinderman A.H.
        Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study.
        Am J Psychiatry. 1994; 151: 1377-1379
        • Waldinger M.D.
        • Olivier B.
        Utility of selective serotonin reuptake inhibitors in premature ejaculation.
        Curr Opin Investig Drugs. 2004; 5: 743-747
        • Kara H.
        • Aydin S.
        • Yucel M.
        • Agargun M.Y.
        • Odabas O.
        • Yilmaz Y.
        The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study.
        J Urol. 1996; 156: 1631-1632
        • Althof S.E.
        • Levine S.B.
        • Corty E.W.
        • Risen C.B.
        • Stern E.B.
        • Kurit D.M.
        A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples.
        J Clin Psychiatry. 1995; 56: 402-407
        • Pfaus J.G.
        • Frank A.
        Beach award. Homologies of animal and human sexual behaviors.
        Horm Behav. 1996; 30: 187-200
        • Brackett N.L.
        • Ferrell S.M.
        • Aballa T.C.
        • et al.
        An analysis of 653 trials of penile vibratory stimulation in men with spinal cord injury.
        J Urol. 1998; 159: 1931-1934
        • McKenna K.E.
        • Chung S.K.
        • McVary K.T.
        A model for the study of sexual function in anesthetized male and female rats.
        Am J Physiol. 1991; 261: R1276-R1285
        • Truitt W.A.
        • Coolen L.M.
        Identification of a potential ejaculation generator in the spinal cord.
        Science. 2002; 297: 1566-1569
        • McKenna K.E.
        • Nadelhaft I.
        The organization of the pudendal nerve in the male and female rat.
        J Comp Neurol. 1986; 248: 532-549
        • Xu C.
        • Yaici E.D.
        • Conrath M.
        • et al.
        Galanin and neurokinin-1 receptor immunoreactivity spinal neurons controlling the prostate and the bulbospongiosus muscle identified by transsynaptic labeling in the rat.
        Neuroscience. 2005; 134: 1325-1341
        • Coolen L.M.
        • Veening J.G.
        • Wells A.B.
        • Shipley M.T.
        Afferent connections of the parvocellular subparafascicular thalamic nucleus in the rat: evidence for functional subdivisions.
        J Comp Neurol. 2003; 463: 132-156
        • Hamson D.K.
        • Watson N.V.
        Regional brainstem expression of Fos associated with sexual behavior in male rats.
        Brain Res. 2004; 1006: 233-240
        • Heeb M.M.
        • Yahr P.
        Anatomical and functional connections among cell groups in the gerbil brain that are activated with ejaculation.
        J Comp Neurol. 2001; 439: 248-258
        • Meisel R.
        • Sachs B.
        The physiology of male sexual behavior.
        in: Knobil E. Neill J. The physiology of reproduction. Raven, New York1994: 3-105
        • Coolen L.M.
        • Peters H.J.
        • Veening J.G.
        Anatomical interrelationships of the medial preoptic area and other brain regions activated following male sexual behavior: a combined Fos and tract-tracing study.
        J Comp Neurol. 1998; 397: 421-435
        • Simerly R.B.
        • Swanson L.W.
        Projections of the medial preoptic nucleus: a Phaseolus vulgaris leucoagglutinin anterograde tract-tracing study in the rat.
        J Comp Neurol. 1988; 270: 209-242
        • Rizvi T.A.
        • Ennis M.
        • Shipley M.T.
        Reciprocal connections between the medial preoptic area and the midbrain periaqueductal gray in rat: A WGA-HRP and PHA-L study.
        J Comp Neurol. 1992; 315: 1-15
        • Murphy A.Z.
        • Rizvi T.A.
        • Ennis M.
        • Shipley M.T.
        The organization of preoptic-medullary circuits in the male rat: evidence for interconnectivity of neural structures involved in reproductive behavior, antinociception and cardiovascular regulation.
        Neuroscience. 1999; 91: 1103-1116
        • Luiten P.G.
        • ter Horst G.J.
        • Karst H.
        • Steffens A.B.
        The course of paraventricular hypothalamic efferents to autonomic structures in medulla and spinal cord.
        Brain Res. 1985; 329: 374-378
        • Saper C.B.
        • Loewy A.D.
        • Swanson L.W.
        • Cowan W.M.
        Direct hypothalamo-autonomic connections.
        Brain Res. 1976; 117: 305-312
        • Canteras N.S.
        • Simerly R.B.
        • Swanson L.W.
        Organization of projections from the medial nucleus of the amygdala: a PHAL study in the rat.
        J Comp Neurol. 1995; 360: 213-245
        • Yasui Y.
        • Saper C.B.
        • Cechetto D.F.
        Calcitonin gene-related peptide (CGRP) immunoreactive projections from the thalamus to the striatum and amygdala in the rat.
        J Comp Neurol. 1991; 308: 293-310
        • Marson L.
        • McKenna K.E.
        A role for 5-hydroxytryptamine in descending inhibition of spinal sexual reflexes.
        Exp Brain Res. 1992; 88: 313-320
        • Marson L.
        • McKenna K.E.
        CNS cell groups involved in the control of the ischiocavernosus and bulbospongiosus muscles: a transneuronal tracing study using pseudorabies virus.
        J Comp Neurol. 1996; 374: 161-179
        • Marson L.
        Lesions of the periaqueductal gray block the medial preoptic area-induced activation of the urethrogenital reflex in male rats.
        Neurosci Lett. 2004; 367: 278-282
        • Murphy A.Z.
        • Hoffman G.E.
        Distribution of gonadal steroid receptor-containing neurons in the preoptic-periaqueductal gray-brainstem pathway: a potential circuit for the initiation of male sexual behavior.
        J Comp Neurol. 2001; 438: 191-212
        • Holstege G.
        • Georgiadis J.R.
        • Paans A.M.
        • Meiners L.C.
        • van der Graaf F.H.
        • Reinders A.A.
        Brain activation during human male ejaculation.
        J Neurosci. 2003; 23: 9185-9193
        • Arnow B.A.
        • Desmond J.E.
        • Banner L.L.
        • et al.
        Brain activation and sexual arousal in healthy, heterosexual males.
        Brain. 2002; 125: 1014-1023
        • Holstege G.
        Central nervous system control of ejaculation.
        World J Urol. 2005; 23: 109-114
        • Perretti A.
        • Catalano A.
        • Mirone V.
        • et al.
        Neurophysiologic evaluation of central–peripheral sensory and motor pudendal pathways in primary premature ejaculation.
        Urology. 2003; 61: 623-628
        • Hull E.M.
        • Muschamp J.W.
        • Sato S.
        Dopamine and serotonin: influences on male sexual behavior.
        Physiol Behav. 2004; 83: 291-307
        • Waldinger M.D.
        • Berendsen H.H.
        • Blok B.F.
        • Olivier B.
        • Holstege G.
        Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system.
        Behav Brain Res. 1998; 92: 111-118
        • Marson L.
        • McKenna K.E.
        The identification of a brainstem site controlling spinal sexual reflexes in male rats.
        Brain Res. 1990; 515: 303-308
        • Renyi L.
        Ejaculations induced by p-chloroamphetamine in the rat.
        Neuropharmacology. 1985; 24: 697-704
        • Yonezawa A.
        • Watanabe C.
        • Ando R.
        • et al.
        Characterization of p-chloroamphetamine-induced penile erection and ejaculation in anesthetized rats.
        Life Sci. 2000; 67: 3031-3039
        • Fernandez-Guasti A.
        • Escalante A.L.
        • Ahlenius S.
        • Hillegaart V.
        • Larsson K.
        Stimulation of 5-HT1A and 5-HT1B receptors in brain regions and its effects on male rat sexual behaviour.
        Eur J Pharmacol. 1992; 210: 121-129
        • Hillegaart V.
        • Ahlenius S.
        • Larsson K.
        Region-selective inhibition of male rat sexual behavior and motor performance by localized forebrain 5-HT injections: a comparison with effects produced by 8-OH-DPAT.
        Behav Brain Res. 1991; 42: 169-180
        • Verma S.
        • China G.S.
        • Mohan Kumar V.
        • Singh B.
        Inhibition of male sexual behavior by serotonin application in the medial preoptic area.
        Physiol Behav. 1989; 46: 327-330
        • Hillegaart V.
        • Ahlenius S.
        • Larsson K.
        Effects of local application of 5-HT into the median and dorsal raphe nuclei on male rat sexual and motor behavior.
        Behav Brain Res. 1989; 33: 279-286
        • Hillegaart V.
        • Ahlenius S.
        Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
        Br J Pharmacol. 1998; 125: 1733-1743
        • Rowland D.L.
        • Houtsmuller E.J.
        8-OH-DPAT interacts with sexual experience and testosterone to affect ejaculatory response in rats.
        Pharmacol Biochem Behav. 1998; 60: 143-149
        • Sharp T.
        • Bramwell S.R.
        • Grahame-Smith D.G.
        5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis.
        Br J Pharmacol. 1989; 96: 283-290
        • Bonvento G.
        • Scatton B.
        • Claustre Y.
        • Rouquier L.
        Effect of local injection of 8-OH-DPAT into the dorsal or median raphe nuclei on extracellular levels of serotonin in serotonergic projection areas in the rat brain.
        Neurosci Lett. 1992; 137: 101-104
        • Clement P.
        • Bernabe J.
        • Kia H.K.
        • Alexandre L.
        • Giuliano F.
        D2-like receptors mediate the expulsion phase of ejaculation elicited by 8-hydroxy-2-(di-N-propylamino)tetralin in rats.
        J Pharmacol Exp Ther. 2006; 316: 830-834
        • Matuszewich L.
        • Lorrain D.S.
        • Trujillo R.
        • Dominguez J.
        • Putnam S.K.
        • Hull E.M.
        Partial antagonism of 8-OH-DPAT’S effects on male rat sexual behavior with a D2, but not a 5-HT1A, antagonist.
        Brain Res. 1999; 820: 55-62
        • Ahlenius S.
        • Larsson K.
        Evidence for an involvement of 5-HT1B receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP.
        Psychopharmacology (Berl). 1998; 137: 374-382
        • Foreman M.M.
        • Hall J.L.
        • Love R.L.
        The role of the 5-HT2 receptor in the regulation of sexual performance of male rats.
        Life Sci. 1989; 45: 1263-1270
        • Blier P.
        • de Montigny C.
        Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat.
        J Neurosci. 1983; 3: 1270-1278
        • Chaput Y.
        • Blier P.
        • de Montigny C.
        In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals.
        J Neurosci. 1986; 6: 2796-2801
        • Blier P.
        • Chaput Y.
        • de Montigny C.
        Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain.
        Naunyn Schmiedebergs Arch Pharmacol. 1988; 337: 246-254
        • Schafer W.R.
        How do antidepressants work? Prospects for genetic analysis of drug mechanisms.
        Cell. 1999; 98: 551-554
        • Al Damluji S.
        The mechanism of action of antidepressants: a unitary hypothesis based on transport-p.
        Curr Drug Targets CNS Neurol Disord. 2004; 3: 201-216
        • Fuller R.W.
        Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis.
        Life Sci. 1994; 55: 163-167
        • de Montigny C.
        • Blier P.
        • Caille G.
        • Kouassi E.
        Pre- and postsynaptic effects of zimelidine and norzimelidine on the serotoninergic system: single cell studies in the rat.
        Acta Psychiatr Scand Suppl. 1981; 290: 79-90
        • Waldinger M.D.
        • Schweitzer D.H.
        • Olivier B.
        On-demand SSRI treatment of premature ejaculation: pharmacodynamic limitations for relevant ejaculation delay and consequent solutions.
        J Sex Med. 2005; 2: 121-131
        • Sprouse J.
        • Braselton J.
        • Reynolds L.
        • Clarke T.
        • Rollema H.
        Activation of postsynaptic 5-HT(1A) receptors by fluoxetine despite the loss of firing-dependent serotonergic input: electrophysiological and neurochemical studies.
        Synapse. 2001; 41: 49-57
        • Sprouse J.
        • Clarke T.
        • Reynolds L.
        • Heym J.
        • Rollema H.
        Comparison of the effects of sertraline and its metabolite desmethylsertraline on blockade of central 5-HT reuptake in vivo.
        Neuropsychopharmacology. 1996; 14: 225-231
        • Anderson G.M.
        Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors (SSRIs) in humans and nonhuman primates: assessing bioeffect and mechanisms of action.
        Int J Dev Neurosci. 2004; 22: 397-404
        • Anderson G.M.
        • Barr C.S.
        • Lindell S.
        • Durham A.C.
        • Shifrovich I.
        • Higley J.D.
        Time course of the effects of the serotonin-selective reuptake inhibitor sertraline on central and peripheral serotonin neurochemistry in the rhesus monkey.
        Psychopharmacology (Berl). 2005; 178: 339-346
        • Frank J.L.
        • Hendricks S.E.
        • Olson C.H.
        Multiple ejaculations and chronic fluoxetine: effects on male rat copulatory behavior.
        Pharmacol Biochem Behav. 2000; 66: 337-342
        • Cantor J.M.
        • Binik Y.M.
        • Pfaus J.G.
        Chronic fluoxetine inhibits sexual behavior in the male rat: reversal with oxytocin.
        Psychopharmacology (Berl). 1999; 144: 355-362
        • Waldinger M.D.
        • van De Plas A.
        • Pattij T.
        • et al.
        The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment.
        Psychopharmacology (Berl). 2002; 160: 283-289
        • Mos J.
        • Mollet I.
        • Tolboom J.T.
        • Waldinger M.D.
        • Olivier B.
        A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat.
        Eur Neuropsychopharmacol. 1999; 9: 123-135
        • Yells D.P.
        • Prendergast M.A.
        • Hendricks S.E.
        • Nakamura M.
        Fluoxetine-induced inhibition of male rat copulatory behavior: modification by lesions of the nucleus paragigantocellularis.
        Pharmacol Biochem Behav. 1994; 49: 121-127
      2. Gengo PJ, Gravitt K, Marson L. Actions of dapoxetine on ejaculation and sexual behaviour in rats. European Society for Sexual Medicine, 8th Congress Copenhagen; 2006.

        • Waldinger M.D.
        Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology.
        Int J Impot Res. 2003; 15: 309-313
        • Haensel S.M.
        • Klem T.M.
        • Hop W.C.
        • Slob A.K.
        Fluoxetine and premature ejaculation: a double-blind, crossover, placebo-controlled study.
        J Clin Psychopharmacol. 1998; 18: 72-77
        • Lee H.S.
        • Song D.H.
        • Kim C.H.
        • Choi H.K.
        An open clinical trial of fluoxetine in the treatment of premature ejaculation.
        J Clin Psychopharmacol. 1996; 16: 379-382
        • Forster P.
        • King J.
        Fluoxetine for premature ejaculation.
        Am J Psychiatry. 1994; 151: 1523
        • Power-Smith P.
        Beneficial sexual side-effects from fluoxetine.
        Br J Psychiatry. 1994; 164: 249-250
        • Biri H.
        • Isen K.
        • Sinik Z.
        • Onaran M.
        • Kupeli B.
        • Bozkirli I.
        Sertraline in the treatment of premature ejaculation: a double-blind placebo controlled study.
        Int Urol Nephrol. 1998; 30: 611-615
        • Mendels J.
        Sertraline for premature ejaculation.
        J Clin Psychiatry. 1995; 56: 591
        • Wise T.N.
        Sertraline as a treatment for premature ejaculation.
        J Clin Psychiatry. 1994; 55: 417
        • Balbay M.D.
        • Yildiz M.
        • Salvarci A.
        • Ozsan O.
        • Ozbek E.
        Treatment of premature ejaculation with sertralin.
        Int Urol Nephrol. 1998; 30: 81-83
        • Ludovico G.M.
        • Corvasce A.
        • Pagliarulo G.
        • Cirillo-Marucco E.
        • Marano A.
        • Pagliarulo A.
        Paroxetine in the treatment of premature ejaculation.
        Br J Urol. 1996; 77: 881-882
        • McMahon C.G.
        • Touma K.
        Treatment of premature ejaculation with paroxetine hydrochloride.
        Int J Impot Res. 1999; 11: 241-245
        • Murat B.M.
        • Atan A.
        • Yildiz M.
        • Baykam M.
        • Aydoganli L.
        Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation.
        Arch Esp Urol. 1999; 52: 1008-1011
        • Waldinger M.D.
        • Hengeveld M.W.
        • Zwinderman A.H.
        • Olivier B.
        Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
        J Clin Psychopharmacol. 1998; 18: 274-281
        • McMahon C.G.
        Ejaculatory dysfunction.
        in: Seftel A.D. Padman-Nathan H. McMahon C.G. Giuliano F. Althof S. Male and female sexual dysfunction. Mosby, London2004: 50-76
        • Abdel-Hamid I.A.
        • El Naggar E.A.
        • El Gilany A.H.
        Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation.
        Int J Impot Res. 2001; 13: 41-45
        • McMahon C.G.
        • Touma K.
        Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies.
        J Urol. 1999; 161: 1826-1830
        • Waldinger M.D.
        • Zwinderman A.H.
        • Olivier B.
        On-demand treatment of premature ejaculation with clomipramine and paroxetine: a randomized, double-blind fixed-dose study with stopwatch assessment.
        Eur Urol. 2004; 46: 510-516
        • Pryor J.L.
        • Althof S.E.
        • Steidle C.
        • Miloslavsky M.
        • Kell S.
        Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation.
        J Urol. 2005; 173: 201
        • Althof S.E.
        Psychological treatment strategies for rapid ejaculation: rationale, practical aspects, and outcome.
        World J Urol. 2005; 23: 89-92
        • Goldstein B.J.
        • Goodnick P.J.
        Selective serotonin reuptake inhibitors in the treatment of affective disorders, III. Tolerability, safety and pharmacoeconomics.
        J Psychopharmacol. 1998; 12: S55-S87
        • Tamam L.
        • Ozpoyraz N.
        Selective serotonin reuptake inhibitor discontinuation syndrome: a review.
        Adv Ther. 2002; 19: 17-26
        • Haddad P.
        The SSRI discontinuation syndrome.
        J Psychopharmacol. 1998; 12: 305-313
        • Black K.
        • Shea C.
        • Dursun S.
        • Kutcher S.
        Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria.
        J Psychiatry Neurosci. 2000; 25: 255-261
        • Nelson E.B.
        • Keck P.E.
        • McElroy S.L.
        Resolution of fluoxetine-induced sexual dysfunction with the 5-HT3 antagonist granisetron.
        J Clin Psychiatry. 1997; 58: 496-497
        • Lane R.
        • Baldwin D.
        Selective serotonin reuptake inhibitor-induced serotonin syndrome: review.
        J Clin Psychopharmacol. 1997; 17: 208-221
        • Montague D.K.
        • Jarow J.
        • Broderick G.A.
        • Dmochowski R.R.
        • Heaton J.P.
        • Lue T.F.
        • et al.
        AUA guideline on the pharmacologic management of premature ejaculation.
        J Urol. 2004; 172: 290-294
        • Semans J.H.
        Premature ejaculation: a new approach.
        South Med J. 1956; 49: 353-358
        • Master W.H.
        • Johnson V.E.
        Human sexual inadequacy.
        Little Brown, Boston1970 (p. 509–41)
        • Clarke M.
        • Parry L.
        Premature ejaculation treated by the dual sex team method of Masters and Johnson.
        Aust N Z J Psychiatry. 1973; 7: 200-205
        • De Amicis L.A.
        • Goldberg D.C.
        • LoPiccolo J.
        • Friedman J.
        • Davies L.
        Clinical follow-up of couples treated for sexual dysfunction.
        Arch Sex Behav. 1985; 14: 467-489
        • Althof S.E.
        Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation.
        J Urol. 2006; 175: 842-848